Osteonecrosis of the jaw as an adverse bisphosphonate event: three cases of bone metastatic prostate cancer patients treated with zoledronic acid. [electronic resource]
- Medicina oral, patologia oral y cirugia bucal Sep 2007
- E351-6 p. digital
Publication Type: Case Reports; Journal Article
1698-6946
Aged Bone Density Conservation Agents--adverse effects Bone Neoplasms--drug therapy Diphosphonates--adverse effects Humans Imidazoles--adverse effects Jaw Diseases--chemically induced Male Middle Aged Osteonecrosis--chemically induced Prostatic Neoplasms--pathology Zoledronic Acid